News Article
Oct 8, 2018
ReViral at 6th ISIRV AVG Conference

ReViral's Chief Operating Officer, Dr Rachel Harland, will be presenting the poster "Efficacy of the RSV fusion Inhibitor RV521 in human infection" at The 6th ISIRV AVG Conference in Washington DC, USA (13th - 15th Nov 2018).